Over 20 cannabis industry CEOs attended the U.S. Cannabis Council's second CEO Summit in Washington D.C. just a few days ago. Benzinga got exclusive inside details on the meetings.
CEOs from the following companies met in D.C. to lobby for cannabis reform:
- Acreage Holdings ACRHF
- Akerna KERN
- Anacostia Organics
- Bridge City Collective
- Canopy Growth CGC
- Central Coast Agriculture/Raw Garden
- The Cronos Group CRON
- Curaleaf CURLF
- Flower One FLOOF
- Greenlane Holdings GNLN
- Holistic Industries
- Marijuana Policy Project
- Standard Wellness
- TrueGreen Global
- Weedmaps MAPS
Senior staff from member companies Dutchie, Foley Hoag, Husch Blackwell and Vicente Sederberg also attended.
The CEOs and their staff arrived Tuesday evening and participated in 60 meetings with Capitol Hill offices on Wednesday and Thursday. They met with members of both parties and both chambers, with a range of opinions on cannabis, ranging from champions like Reps. Joyce and Perlmutter to current opponents of legalization.
Rep. Nancy Mace met CEOs and spoke at the reception on Wednesday night.
Many of the CEOs also attended two onsite fundraisers – one Democrat and one Republican, which were organized by the campaigns.
What CEOs Are Saying
Canopy Growth CEO David Klein was “even more encouraged by the bipartisan support for federal cannabis reform on Capitol Hill,” following the discussions with key Congressional stakeholders.
“What was most evident during our conversations is the shared responsibility we have to drive legalization forward as we seek to jumpstart the U.S. economy and unlock the 1.2 million high quality jobs that federal legalization can create,” he said.
Jessica Billingsley, CEO of Akerna and Chair of US Cannabis Council added that these conversations about federal cannabis reform have shifted from “if” to “when” and “how” this eventuality will occur: “We are already working on specific strategies and legislative vehicles for the short term, followed by our longer-term goal of achieving full US federal legalization and descheduling of cannabis.”
Christian Sederberg, founding partner of Vicente Sederberg LLP, also weighed in exclusively.
“Members of Congress are more knowledgeable about key cannabis policy matters than ever before. They know the legal cannabis industry is now a significant driver of jobs and commerce in many states around the country, and they appreciate the urgency around reform at the federal level. We were pleased to find they were upbeat about the prospects for this session,” he voiced.
Finally, Kellen O’Keefe, CEO of Flower One called for more expedited action.
“The time to legalize and regulate cannabis is now. We have the support of the American people and need our elected officials in Washington to work together on incremental reform such as the Safe Banking Act,” said O’Keefe. “Our industry is the fastest-growing, highest tax-paying, job-creating, and community-enriching industry on the planet. It’s about time we get the support we need to ensure we can build a sustainable and equitable future for cannabis.”
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Missed the first wave of cannabis investments? Don’t make that mistake again.
Experts believe cannabis stocks have found their floor and are now poised for unprecedented growth.
Join Benzinga PotProfits. Our in-house canna stock expert, Michael Berger, is on a mission to uncover the most promising cannabis stocks poised for growth, even in a dull market. He leaves no bud unturned to bring you the juiciest potential double-digit opportunities!
Just this year, the PotProfits portfolio has seen smoking-hot gains like:
- 47.10% with $GTBIF
- 40.23% with $TCNNF
- 21.50% with $VFF